• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用深度学习分类进行自动球体生成、药物应用和疗效筛选:一项可行性研究。

Automated spheroid generation, drug application and efficacy screening using a deep learning classification: a feasibility study.

机构信息

Department of Plastic and Hand Surgery, Faculty of Medicine, Medical Center, University of Freiburg, Freiburg, Germany.

Department of Computer Science, University of Innsbruck, Innsbruck, Austria.

出版信息

Sci Rep. 2020 Jul 6;10(1):11071. doi: 10.1038/s41598-020-67960-0.

DOI:10.1038/s41598-020-67960-0
PMID:32632214
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7338379/
Abstract

The last two decades saw the establishment of three-dimensional (3D) cell cultures as an acknowledged tool to investigate cell behaviour in a tissue-like environment. Cells growing in spheroids differentiate and develop different characteristics in comparison to their two-dimensionally grown counterparts and are hence seen to exhibit a more in vivo-like phenotype. However, generating, treating and analysing spheroids in high quantities remains labour intensive and therefore limits its applicability in drugs and compound research. Here we present a fully automated pipetting robot that is able to (a) seed hanging drops from single cell suspensions, (b) treat the spheroids formed in these hanging drops with drugs and (c) analyse the viability of the spheroids by an image-based deep learning based convolutional neuronal network (CNN). The model is trained to classify between 'unaffected', 'mildly affected' and 'affected' spheroids after drug exposure. All corresponding spheroids are initially analysed by viability flow cytometry analysis to build a labelled training set for the CNN to subsequently reduce the number of misclassifications. Hence, this approach allows to efficiently examine the efficacy of drug combinatorics or new compounds in 3D cell culture. Additionally, it may provide a valuable instrument to screen for new and individualized systemic therapeutic strategies in second and third line treatment of solid malignancies using patient derived primary cells.

摘要

过去二十年见证了三维(3D)细胞培养的建立,它被公认为研究组织样环境中细胞行为的工具。与二维培养的细胞相比,在球体中生长的细胞分化并表现出不同的特征,因此表现出更类似于体内的表型。然而,生成、处理和分析大量球体仍然是劳动密集型的,因此限制了其在药物和化合物研究中的应用。在这里,我们展示了一种完全自动化的移液机器人,它能够(a)从单细胞悬浮液中接种悬滴,(b)用药物处理这些悬滴中形成的球体,(c)通过基于图像的深度学习卷积神经网络(CNN)分析球体的活力。该模型经过训练,可以在药物暴露后对“未受影响”、“轻度受影响”和“受影响”的球体进行分类。所有相应的球体最初都通过活力流式细胞术分析进行分析,以构建 CNN 的标记训练集,随后减少误分类的数量。因此,这种方法可以有效地研究药物组合或新化合物在 3D 细胞培养中的功效。此外,它可能为使用患者来源的原代细胞在实体恶性肿瘤的二线和三线治疗中筛选新的和个体化的系统治疗策略提供有价值的工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c7b/7338379/af4073426d17/41598_2020_67960_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c7b/7338379/a83f4e463b4b/41598_2020_67960_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c7b/7338379/f9cc358086fc/41598_2020_67960_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c7b/7338379/f8321fc3c819/41598_2020_67960_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c7b/7338379/af4073426d17/41598_2020_67960_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c7b/7338379/a83f4e463b4b/41598_2020_67960_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c7b/7338379/f9cc358086fc/41598_2020_67960_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c7b/7338379/f8321fc3c819/41598_2020_67960_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c7b/7338379/af4073426d17/41598_2020_67960_Fig4_HTML.jpg

相似文献

1
Automated spheroid generation, drug application and efficacy screening using a deep learning classification: a feasibility study.利用深度学习分类进行自动球体生成、药物应用和疗效筛选:一项可行性研究。
Sci Rep. 2020 Jul 6;10(1):11071. doi: 10.1038/s41598-020-67960-0.
2
Digital microfluidics for automated hanging drop cell spheroid culture.用于自动悬滴细胞球体培养的数字微流控技术。
J Lab Autom. 2015 Jun;20(3):283-95. doi: 10.1177/2211068214562002. Epub 2014 Dec 15.
3
Deep learning unlocks label-free viability assessment of cancer spheroids in microfluidics.深度学习解锁微流控中无标记的癌症球体活力评估。
Lab Chip. 2024 Jun 11;24(12):3169-3182. doi: 10.1039/d4lc00197d.
4
Real-time viability and apoptosis kinetic detection method of 3D multicellular tumor spheroids using the Celigo Image Cytometer.使用 Celigo 图像细胞仪实时检测三维多细胞肿瘤球体的活力和细胞凋亡动力学。
Cytometry A. 2017 Sep;91(9):883-892. doi: 10.1002/cyto.a.23143. Epub 2017 Jun 15.
5
SpheroidPicker for automated 3D cell culture manipulation using deep learning.使用深度学习的自动化 3D 细胞培养操作的球状体选择器。
Sci Rep. 2021 Jul 20;11(1):14813. doi: 10.1038/s41598-021-94217-1.
6
Reprint of: A three-dimensional in vitro HepG2 cells liver spheroid model for genotoxicity studies.重印:用于遗传毒性研究的三维体外 HepG2 细胞肝球体模型。
Mutat Res Genet Toxicol Environ Mutagen. 2018 Oct;834:35-41. doi: 10.1016/j.mrgentox.2018.06.020. Epub 2018 Aug 18.
7
Robotic production of cancer cell spheroids with an aqueous two-phase system for drug testing.用于药物测试的具有双水相系统的癌细胞球状体的机器人生产。
J Vis Exp. 2015 Apr 23(98):e52754. doi: 10.3791/52754.
8
Spheroid preparation from hanging drops: characterization of a model of brain tumor invasion.悬滴法制备球体:脑肿瘤侵袭模型的表征
J Neurooncol. 2004 May;67(3):295-303. doi: 10.1023/b:neon.0000024220.07063.70.
9
Utilizing convolutional neural networks for discriminating cancer and stromal cells in three-dimensional cell culture images with nuclei counterstain.利用卷积神经网络对核染色的三维细胞培养图像中的癌细胞和基质细胞进行区分。
J Biomed Opt. 2024 Jun;29(Suppl 2):S22710. doi: 10.1117/1.JBO.29.S2.S22710. Epub 2024 Aug 24.
10
On-chip anticancer drug test of regular tumor spheroids formed in microwells by a distributive microchannel network.微流控网络分配式微通道中常规肿瘤球体的片上抗癌药物测试。
Lab Chip. 2012 Oct 21;12(20):4135-42. doi: 10.1039/c2lc40570a.

引用本文的文献

1
Label-Free Machine Learning Prediction of Chemotherapy on Tumor Spheroids Using a Microfluidics Droplet Platform.使用微流控液滴平台对肿瘤球体进行化疗的无标记机器学习预测
Small Sci. 2025 Jul 16;5(9):2500173. doi: 10.1002/smsc.202500173. eCollection 2025 Sep.
2
The Evolution of Anticancer 3D In Vitro Models: The Potential Role of Machine Learning and AI in the Next Generation of Animal-Free Experiments.抗癌3D体外模型的演变:机器学习和人工智能在下一代无动物实验中的潜在作用。
Cancers (Basel). 2025 Feb 19;17(4):700. doi: 10.3390/cancers17040700.
3
Deep Learning for Predicting Spheroid Viability: Novel Convolutional Neural Network Model for Automating Quality Control for Three-Dimensional Bioprinting.

本文引用的文献

1
Cells grown in three-dimensional spheroids mirror in vivo metabolic response of epithelial cells.在三维球体中生长的细胞反映了上皮细胞的体内代谢反应。
Commun Biol. 2020 May 19;3(1):246. doi: 10.1038/s42003-020-0973-6.
2
Cancer modeling meets human organoid technology.癌症建模与人类类器官技术相遇。
Science. 2019 Jun 7;364(6444):952-955. doi: 10.1126/science.aaw6985.
3
Machine learning, practically speaking.实际上的机器学习。
用于预测球体活力的深度学习:用于三维生物打印质量控制自动化的新型卷积神经网络模型
Bioengineering (Basel). 2025 Jan 1;12(1):28. doi: 10.3390/bioengineering12010028.
4
High-Throughput Chemotherapeutic Drug Screening System for Gastric Cancer (Cure-GA).胃癌高通量化疗药物筛选系统(Cure-GA)。
Ann Surg Oncol. 2025 May;32(5):3781-3795. doi: 10.1245/s10434-024-16850-0. Epub 2025 Jan 23.
5
High-throughput platform for label-free sorting of 3D spheroids using deep learning.利用深度学习对三维球体进行无标记分选的高通量平台。
Front Bioeng Biotechnol. 2024 Dec 9;12:1432737. doi: 10.3389/fbioe.2024.1432737. eCollection 2024.
6
A spheroid whole mount drug testing pipeline with machine-learning based image analysis identifies cell-type specific differences in drug efficacy on a single-cell level.一种基于机器学习图像分析的球体整装药物测试流程可在单细胞水平上识别药物疗效的细胞类型特异性差异。
BMC Cancer. 2024 Dec 18;24(1):1542. doi: 10.1186/s12885-024-13329-9.
7
AI-driven 3D bioprinting for regenerative medicine: From bench to bedside.用于再生医学的人工智能驱动的3D生物打印:从实验室到临床应用
Bioact Mater. 2024 Nov 23;45:201-230. doi: 10.1016/j.bioactmat.2024.11.021. eCollection 2025 Mar.
8
Non-small cell lung cancer organoids: Advances and challenges in current applications.非小细胞肺癌类器官:当前应用中的进展与挑战
Chin J Cancer Res. 2024 Oct 30;36(5):455-473. doi: 10.21147/j.issn.1000-9604.2024.05.01.
9
Automated Uniform Spheroid Generation Platform for High Throughput Drug Screening Process.高通量药物筛选过程用自动化均一球体生成平台。
Biosensors (Basel). 2024 Aug 15;14(8):392. doi: 10.3390/bios14080392.
10
Optical coherence tomography for multicellular tumor spheroid category recognition and drug screening classification via multi-spatial-superficial-parameter and machine learning.基于多空间表面参数和机器学习的光学相干断层扫描用于多细胞肿瘤球体分类识别及药物筛选分类
Biomed Opt Express. 2024 Mar 4;15(4):2014-2047. doi: 10.1364/BOE.514079. eCollection 2024 Apr 1.
Nat Methods. 2019 Jun;16(6):463-467. doi: 10.1038/s41592-019-0432-9.
4
A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia.一种用于鉴定慢性淋巴细胞白血病中新型NFAT2靶基因的染色质免疫沉淀分析
J Vis Exp. 2018 Dec 4(142). doi: 10.3791/58270.
5
A framework for the development of effective anti-metastatic agents.一种有效的抗转移药物的开发框架。
Nat Rev Clin Oncol. 2019 Mar;16(3):185-204. doi: 10.1038/s41571-018-0134-8.
6
Man against machine: diagnostic performance of a deep learning convolutional neural network for dermoscopic melanoma recognition in comparison to 58 dermatologists.人机大战:深度学习卷积神经网络与 58 位皮肤科医生诊断黑色素瘤皮肤镜图像的对比研究
Ann Oncol. 2018 Aug 1;29(8):1836-1842. doi: 10.1093/annonc/mdy166.
7
Comprehensive high-throughput image analysis for therapeutic efficacy of architecturally complex heterotypic organoids.针对结构复杂的异质类器官的治疗效果进行全面高通量的图像分析。
Sci Rep. 2017 Nov 30;7(1):16645. doi: 10.1038/s41598-017-16622-9.
8
Unravelling the complexity of signalling networks in cancer: A review of the increasing role for computational modelling.解析癌症信号网络的复杂性:计算建模作用日益增强的综述
Crit Rev Oncol Hematol. 2017 Sep;117:73-113. doi: 10.1016/j.critrevonc.2017.06.004. Epub 2017 Jun 23.
9
Role of apoptosis in the development of autosomal dominant polycystic kidney disease (ADPKD).细胞凋亡在常染色体显性多囊肾病(ADPKD)发展中的作用。
Cell Tissue Res. 2017 Jul;369(1):27-39. doi: 10.1007/s00441-017-2628-6. Epub 2017 May 30.
10
Modeling the process of human tumorigenesis.建立人类肿瘤发生过程的模型。
Nat Commun. 2017 May 25;8:15422. doi: 10.1038/ncomms15422.